Select Page
ONEpossible 2022

ONEpossible 2022

In 2020, PRF checked off an important mission milestone: U.S. Food and Drug Administration (FDA) approval of lonafarnib (brand name Zokinvy®), the first-ever treatment for Progeria. Since then, and through tremendous effort and expense, PRF and partner Eiger...